📰 Medication Guide News

Page 26 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer

April 16, 2023

Results from Phase 3 KEYNOTE-966 to be presented at AACR 2023 Annual Meeting during Clinical Trials Plenary Session, included in official meeting press program and published simultaneously in The... | April 16, 2023

United States San Francisco Robin Kate Kelley Merck Co Inc Statement Of Merck Co Inc Exchange Commission

Source: marketscreener.com

Incyte and MorphoSys U.S. Inc.: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi (tafasitamab-cxix)

April 16, 2023

Results from the Phase 2 L-MIND study were highlighted as a late-breaking oral presentation at the American Association for Cancer Research Annual Meeting 2023 MorphoSys U.S. Inc., a fully owned subsidiary

United States University Hospital Steven Stein Johannes Duell Kaitlyn Nealy Julia Neugebauer

Source: finanznachrichten.de

EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi (tafasitamab-cxix)

April 16, 2023

16.04.2023 - EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi (tafasitamab-cxix) 16.04.2023 / ...

United States University Hospital Johannes Duell Tim Demuth Steven Stein Morphosys Us Inc

Source: wallstreet-online.de

Moderna, Inc.: Moderna and Merck Announce mRNA-4157 , an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA , Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete R

April 16, 2023

MRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients with high risk of recurrence following complete

United States United Kingdom Mary Beth Woodin Peter Dannenbaum Lavina Talukdar Justine Moore

Source: finanznachrichten.de

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

April 16, 2023

- Results from the Phase 2 L-MIND study were highlighted as a late-breaking oral presentation at the American Association for Cancer Research Annual Meeting 2023 ... | June 19, 2023

United States University Hospital Tim Demuth Steven Stein Johannes Duell Exchange Commission

Source: marketscreener.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

-SCOTUS Issues Administrative Stay-

April 15, 2023

/PRNewswire/ -- This afternoon, the US Supreme Court issued an administrative stay of the April 7 order from Judge Matthew Kacsmaryk of the US District Court...

United States Matthew Kacsmaryk Public Affairs Us District Court Us Supreme Court Supreme Court

Source: prnewswire.com

FDA Updates Opioid Analgesic Labeling to Help Guide Prescribing Decisions

April 14, 2023

The FDA has updated the prescribing information for all opioid analgesics in order to provide additional guidance on how to safely prescribe these medications.

Drug Administration Boxed Warning Medication Guide

Source: empr.com

Pride, not shame, along an alcohol dependence recovery journey

April 14, 2023

An LGBTQ+ perspective on living openly and leaving alcohol behind.

United States Substance Abuse Center Alkermes Inc Community Impact Behavioral Health Statistics Mental Health Services Administration

Source: usatoday.com

I Never Thought I'd Get Injectables—Here's Why I Finally Did

April 14, 2023

Influencer Laticia Rolle opens up about the beauty treatment that helps her streamline her regimen. For full Prescribing Information including BOXED WARNING and Medication Guide, visit XeominAesthetic.com. Please see full Important Consumer Safety Information at the side of this article.

New York United States Laticia Rolle Nicole Catanese Michelle Henry Merz North America Inc

Source: cosmopolitan.com